Awakn Life Sciences has opened a clinic offering ketamine-assisted psychotherapy in the UK, becoming the first of its kind in
Awakn Life Sciences has opened a clinic offering ketamine-assisted psychotherapy in the UK, becoming the first of its kind in
Recently published results of The Global Drug Survey have revealed the behaviour and experiences of people using the likes of psilocybin, LSD,
Researchers from Imperial College London have carried out the largest placebo-controlled trial into psychedelics to date and found that small
During The PSYCH Symposium in November 2020, a panel of leading scientists discussed their work in the field of psychedelic
During The PSYCH Symposium in November 2020, a panel of leading experts operating in psychedelics sector, discussed the cultural challenge
Last week, the world’s first exchange-traded fund for psychedelic medicines companies made its debut in Toronto, as the investment sector
During The PSYCH Symposium in November 2020, a panel of leading experts,operating in psychedelics sector discussed the advancement of research
During The PSYCH Symposium in November 2020, Professor David Nutt, chairman of Awakn Life Sciences, founder of Drug Science and the
A new company straddling both the functional health and psychedelic space with a consumer/retail first approach. Backed by a leading
Exclusive: Saint Vincent and the Grenadines announces initiative to permit psychedelic treatment and research The Caribbean nation of Saint Vincent
For the first time, stock in a psychedelic medicine company was traded on the market – and it was major
Field Trip Health Ltd. (CSE: FTRP) began trading shares on the Canadian Securities Exchange on Tuesday 6th October, opening at $3.50